Influence of unrecognized molecular heterogeneity on randomized clinical trials (Q45306049)
scientific article
Language:
Current Data About Influence of unrecognized molecular heterogeneity on randomized clinical trials
(P31) (Q13442814)
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P50) (Q42290664)
(P1545) 1
(P1932) Rebecca A Betensky
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(Q114727084)
(P1545) 3
(P1932) J Gregory Cairncross
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P304) 2495-2499
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P407) (Q1860)

(P433) 10
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P478) 20
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P577) Wednesday, May 1, 2002
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P921) (Q928498)
(P887)

(P1433) (Q400292)
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P1476) "Influence of unrecognized molecular heterogeneity on randomized clinical trials" (language: en)
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P2093) David N Louis
(P1545) 2
(P248)
(P698) 12011127
(P813) Monday, December 11, 2017

(P2860) (Q27860529)
(P248)
(P813) Tuesday, May 24, 2022
(P854) https://opencitations.net/index/coci/api/v1/citations/10.1038/35000501

other details
description scientific article

External Links
(P356) 10.1200/JCO.2002.06.140
(P698) 12011127